A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies (Q2341238)

From MaRDI portal
Revision as of 06:46, 5 March 2024 by Import240304020342 (talk | contribs) (Set profile property.)
scientific article
Language Label Description Also known as
English
A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies
scientific article

    Statements

    A hybrid fuzzy MCDM method for measuring the performance of publicly held pharmaceutical companies (English)
    0 references
    0 references
    0 references
    0 references
    23 April 2015
    0 references
    performance evaluation
    0 references
    balanced scorecard
    0 references
    DEMATEL
    0 references
    fuzzy ANP
    0 references
    fuzzy DEA
    0 references

    Identifiers